Jose Breton's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 150,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 5, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 15,000 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 15,000 | 17,169 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 5,250 | 11,919 (0%) | 0% | 1.1 | 5,985 | Common Stock |
| Fresh Tracks Therapeutics Inc | Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |